Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.

Sandoval, C

Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun 1993 - 1039-45 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.1993.11.6.1039 doi


Acute Disease
Adolescent
Alkylating Agents--adverse effects
Antineoplastic Agents--adverse effects
Child
Combined Modality Therapy
Dactinomycin--adverse effects
Doxorubicin--adverse effects
Female
Humans
Intercalating Agents--adverse effects
Leukemia, Myeloid--etiology
Male
Neoplasms, Second Primary--etiology
Podophyllotoxin--adverse effects
Radiotherapy--adverse effects
Topoisomerase II Inhibitors
Translocation, Genetic